We are live on ! Find out more
TCA

Transcend Capital Advisors Portfolio holdings

AUM $1.25B
1-Year Est. Return 17.69%
This Fund
S&P 500
This Quarter Est. Return
-2.97%
1 Year Est. Return
+17.69%
3 Year Est. Return
+61.21%
5 Year Est. Return
+70.44%
10 Year Est. Return
AUM
$1.03B
AUM Growth
-$22.9M
Cap. Flow
+$10.3M
Cap. Flow %
1%
Top 10 Hldgs %
29.21%
Holding
518
New
31
Increased
189
Reduced
206
Closed
28

Sector Composition

Rank Sector Weight
1 Technology 19.17%
2 Financials 17.11%
3 Healthcare 10.22%
4 Consumer Discretionary 4.85%
5 Communication Services 3.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRME icon
501
First Merchants
FRME
$2.69B
-8,484
Closed -$240K
FXH icon
502
First Trust Health Care AlphaDEX Fund
FXH
$1.05B
-1,931
Closed -$209K
IHE icon
503
iShares US Pharmaceuticals ETF
IHE
$1.49B
-3,372
Closed -$201K
LRCX icon
504
Lam Research
LRCX
$316B
-3,320
Closed -$214K
MPT
505
Medical Properties Trust
MPT
$2.84B
-19,188
Closed -$178K
OTLK icon
506
Outlook Therapeutics
OTLK
$187M
-500
Closed -$17.4K
POR icon
507
Portland General Electric
POR
$5.82B
-4,693
Closed -$220K
PPG icon
508
PPG Industries
PPG
$24.9B
-5,431
Closed -$805K
RACE icon
509
Ferrari
RACE
$67.8B
-693
Closed -$225K
SRPT icon
510
Sarepta Therapeutics
SRPT
$1.64B
-2,000
Closed -$229K
SYY icon
511
Sysco
SYY
$40.8B
-2,775
Closed -$206K
TFI icon
512
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$3.06B
-44,489
Closed -$2.05M
WBD icon
513
Warner Bros
WBD
$64.3B
-12,129
Closed -$152K
XRX icon
514
Xerox
XRX
$345M
-20,145
Closed -$300K
VRTV
515
DELISTED
VERITIV CORPORATION
VRTV
-3,800
Closed -$477K
RETA
516
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
-3,000
Closed -$306K
RSX
517
DELISTED
VanEck Russia ETF
RSX
$0 ﹤0.01%
130,665
BSCN
518
DELISTED
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
-13,120
Closed -$278K

Similar funds

Transcend Capital Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Transcend Capital Advisors held 518 positions worth $1.03B, down 2.2% from $1.05B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Transcend Capital Advisors's Q3 2023 filing shows 31 new, 189 increased, 206 reduced and 28 closed positions. Its largest new stake was iShares US Medical Devices ETF: 47,945 shares worth $2.33M. The largest sale was iShares 10-20 Year Treasury Bond ETF, an estimated $3.94M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

  • Transcend Capital Advisors's largest Q3 2023 buy was iShares US Medical Devices ETF: 47,945 shares worth $2.33M.
  • Transcend Capital Advisors added most to Johnson & Johnson in Q3 2023, an estimated $10M increase.
  • Transcend Capital Advisors's biggest Q3 2023 reduction was iShares 10-20 Year Treasury Bond ETF, cutting an estimated $3.94M.
  • Transcend Capital Advisors fully exited State Street SPDR Nuveen ICE Municipal Bond ETF in Q3 2023, selling an estimated $2.05M.
  • Transcend Capital Advisors's ten largest holdings make up 29% of its $1.03B portfolio in Q3 2023.
  • Transcend Capital Advisors opened 31 new positions and closed 28 in Q3 2023.
  • Transcend Capital Advisors's portfolio value fell 2.2% quarter-over-quarter to $1.03B.

Based on Transcend Capital Advisors's 13F filing for Q3 2023, filed 31 Oct 2023.